Quick Answer
COMPASS Pathways plc reported Research And Development Expense of $118.44 million for the year ending 2025.
- COMPASS Pathways plc showed a decrease of -0.5% in Research And Development Expense from 2024 to 2025.
- This data is from COMPASS Pathways plc's annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $6.88 million | Q2 2021: $11.35 million | Q3 2021: $12.20 million | Q1 2022: $15.36 million | Q2 2022: $15.92 million | Q3 2022: $13.98 million | Q1 2023: $19.04 million | Q2 2023: $19.82 million | Q3 2023: $21.53 million | Q1 2024: $24.90 million | Q2 2024: $29.07 million | Q3 2024: $32.93 million | Q1 2025: $30.88 million | Q2 2025: $30.33 million | Q3 2025: $27.33 million.
- Over the full 7 years of available data (2019 to 2025), COMPASS Pathways plc's Research And Development Expense has grown by 842.7%.
- Historical annual values: Fiscal year 2025: $118.44 million | Fiscal year 2024: $119.04 million | Fiscal year 2023: $87.52 million | Fiscal year 2022: $65.05 million | Fiscal year 2021: $44.03 million | Fiscal year 2020: $23.37 million | Fiscal year 2019: $12.56 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: